Glucose Metabolism Disorders  >>  Suglat (ipragliflozin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Suglat (ipragliflozin) / EMD Serono, Kotobuki, Astellas
BALANCE, NCT01117584 / 2009-013881-25: A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus

Checkmark Data
Nov 2011 - Nov 2011: Data
Checkmark Data
Aug 2011 - Aug 2011: Data
Completed
2b
343
US, Europe
ipragliflozin, ASP1941, Placebo, Metformin
Astellas Pharma Inc
Type 2 Diabetes Mellitus
04/11
04/11
NCT00790660: A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.

Completed
2a
61
US
ASP1941, Placebo
Astellas Pharma Inc
Diabetes Mellitus, Type 2
03/09
03/09
NCT02529449: Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus

Completed
2
43
Japan
Placebo, ASP1941, Suglat, Ipragliflozin
Astellas Pharma Inc
Type 1 Diabetes Mellitus
03/16
03/16

Download Options